Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
107 participants
OBSERVATIONAL
2015-01-01
2020-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondly to correlate zinc to copper ratio with lipocalin 2 (Lcn2) with respect to Anthropometric measurements and other metabolic biomarkers.
Prospective study will be carried out on 120 morbidly obese adult subjects with a body mass index (BMI) score above 40 along with presence of obesity-related comorbidity. Investigations will be measured preoperative and 9 months postoperative after performing Laparoscopic sleeve gastrectomy; for Body mass index (BMI) and waist circumference. As well as for complete blood count and biochemical biomarkers as fasting blood glucose, lipid profile, serum iron and ferritin. Serum Ceruloplasmin, Zn and Cu levels, followed by calculation of zinc to copper ratio. CRP, serum insulin, serum leptin and lipocalin-2 (Lcn2) will be determined.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nutritional Status of Patients Before and After Bariatric Surgery
NCT03915158
Vitamin and Mineral Supplementation Post Bariatric Surgery
NCT02817256
Evaluation of Bariatric Surgery Patients Before and After Sleeve Gastrectomy in Terms of Nutritional Status
NCT05690139
Nutritional Deficiency After Bariatric Surgeries
NCT04717973
Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome
NCT05408728
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Materials and methods:
Recruitment Morbidly obese subjects attending clinic at Surgery department for laparoscopic sleeve gastrectomy Alexandria University Hospitals.
Pre-assignment Details adult morbidly obese subjects were included age above 20 years, BMI above 40 Suffering from comorbidities as hypertension, DM, dyslipidemia. Assigned participants were clinically evaluated for comorbidities as hypertension, DM, dyslipidemia.
As well as signs of nutritional deficiency as anemia, brittle nails.
Group Information one group of participants eligible for laparoscopic sleeve gastrectomy were assigned according to their will to participate in study.
Period of evaluation:
First visit: preoperative for clinical assessment of participants, determine BMI and waist circumference and withdrawal of serum blood sample Second visit: within one month after surgery to make sure that no complication occurred after surgery.
Third visit: nine months postoperative for revaluation of participants, determine BMI and waist circumference, and withdrawal of a serum blood sample
Number of participants at initiating the period of study. They were 120 morbidly obese subjects. Number of participants at the end of the period of study. They were 107 subjects, 13 obese subject withdraw from study as they didn't come during follow up period after 9 months.
Participants according Sex (69 females, and 38 male), with the mean age of 41.6±8.9 years. The mean preoperative BMI was 47.43±5.4 kg/m2. Then, they were evaluated 9 months after LSG.
Preoperative and Postoperative Clinical characteristics and metabolic variables in studied subjects.
Preoperative 9 months postoperative P Body weight (Kg) 129.7 ± 12.1 93.4 ±13.6 0.0013\* BMI (kg/m2) 47.43±5.4 35.7±3.8 0.0052\* Waist circumference (cm) 130.00 ± 4.68 91.82 ± 3.73 0.001\* Systolic BP (mmHg) 146.0±17.0 132.0±11.0 0.001\* Total cholesterol (mmol/L) 5.85 ± 0.41 4.64 ± 0.31 0.035\* Triglycerides (mmol/L) 2.20 ± 0.23 1.92 ± 0.24 0.106 HDL cholesterol (mmol/L) 1.23 ± 0.19 1.39 ± 0.2 0.041\* LDL cholesterol (mmol/L) 3.37 ± 0.23 2.97 ± 0.21 0.022\* HOMA-IR 2.64 ± 1.3 1.44 ± 0.81 0.013\* S. Leptin (ng/ml) 102.87 ± 49.16 33.47 ±12.76 0.0001\* CRP (mg/L) 8.4±5.91 3.2±2.98 0.001\* Lipocalin 2 (µg/L) 107.24±36.8 51.6±12.73 0.001\* Albumin (g/dl) 4.05±0.21 3.91±0.29 0.113
\*Statistically significant at (p≤0.05).
Outcome measures:
primarily was to investigate the value of zinc to copper ratio as possible biomarker of TE imbalance in morbidly obese subjects undergoing LSG.
For detection of presence of micronutrient deficiency in morbid obesity in form of zinc to copper ratio and re-evaluate it after loss of weight
Secondly to correlate it with lipocalin 2 (Lcn2) with respect to Anthropometric measurements and other metabolic markers prospectively.
As zinc to copper ratio is considered as biomarker of micronutrient status; therefore, correlate it with other biomarkers of inflammation (lipocalin 2) and other parameters as BMI, FBG to determine if micronutrient status improve after weight loss or not Time frame: 9 months.
Follow-up and outcome parameters:
All studied subjects will be followed up for early postoperative complications (within the first month) as Bleeding or Leak. Then they will be reviewed after 9 months postoperatively for assessment of anthropometric measurements, control of preoperative comorbidities, and manifestations of TE deficiencies (anemia, hair loss, teeth problems, edema. etc.).
Anthropometric parameters
Body mass index (BMI) and waist circumference will be measured preoperative and 9 months postoperative.
Biochemical parameters
Fasting blood samples will be collected from participants prior to surgery and nine months postoperative, after overnight fast and divided into two tubes; EDTA for complete blood count, the rest into plastic tubes and serum sample.
Serum glucose and Total cholesterol, HDL- cholesterol, LDL- cholesterol, and triglyceride, total protein and Albumin. Serum iron (Fe), and ferritin.
Serum insulin, Ceruloplasmin, Zn and Cu levels, CRP and lipocalin-2 (Lcn2) .
Statistical analysis
All data will be analyzed with Statistical Package for the Social Sciences version 20 software (SPSS, Inc., Chicago, IL). Results will be displayed as mean ± SD. Paired Student's t-test used to compare the data pre-operative and nine months postoperative. The chi-squared test used for category variables. Spearman correlation coefficient used to detect the correlation between different variables. Statistical correlations calculated by Pearson's correlation test. P \< 0.05 is considered significant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Preoperative Clinical characteristics and metabolic biomarkers
BMI and biochemical parameters including trace elements in patients undergoing laparoscopic sleeve gastrectomy before surgery
laparoscopic sleeve gastrectomy
bariatric surgery to loss weight
9 months' Postoperative metabolic biomarkers
BMI and biochemical parameters including trace elements in patients 9 months after laparoscopic sleeve gastrectomy
laparoscopic sleeve gastrectomy
bariatric surgery to loss weight
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
laparoscopic sleeve gastrectomy
bariatric surgery to loss weight
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI above 40
* presence of comorbidities as hypertenion, DM, dislipidemia
Exclusion Criteria
* all causes which may cause increase obesity "BMI" as hormonal disturbance ; hypothyroidism or cushing, females receiving contraceptive pills
20 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
hala mourad demerdash
Consultant Clinical Pathology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hala M Demerdash, MD
Role: PRINCIPAL_INVESTIGATOR
Alexandria University Hospitals
References
Explore related publications, articles, or registry entries linked to this study.
Yerlikaya FH, Toker A, Aribas A. Serum trace elements in obese women with or without diabetes. Indian J Med Res. 2013 Feb;137(2):339-45.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00018699
Identifier Type: REGISTRY
Identifier Source: secondary_id
00012098
Identifier Type: REGISTRY
Identifier Source: secondary_id
0304707
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.